Intrathecal autologous bone marrow stem cell therapy in children with autism: A randomized controlled trial.

Narges SharifzadehAli GhasemiJalil Tavakol AfshariFatemeh MoharariAtefeh SoltanifarAli TalaeiHamid Reza PouryousofMahsa NahidiMohammad Reza Fayyazi BordbarMaliheh Ziaee

Published in: Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists (2020)

Intrathecal injection of autologous BMMSCs seems to be safe and feasible, but has limited clinical efficacy in treatment of children with ASD.

Keyphrases

bone marrow
stem cells
autism spectrum disorder
young adults
cell therapy
mesenchymal stem cells
intellectual disability
platelet rich plasma
attention deficit hyperactivity disorder
combination therapy
ultrasound guided